Lyell Immunopharma, Inc. — Investor Relations & Filings
Filings indexed
291
across all filing types
Latest filing
2026-04-24
Annual Report
Country
US
United States of America
Listing
US
LYEL
Lyell Immunopharma, Inc. is a clinical-stage cell therapy company that develops Chimeric Antigen Receptor (CAR) T-cell therapies for cancer. The company pioneers T-cell reprogramming technologies designed to overcome the primary barriers to durable clinical responses in patients. Its scientific approach focuses on enhancing T-cell function and fitness to improve the efficacy and persistence of its therapeutic candidates. Lyell's pipeline targets both solid tumors and hematologic malignancies, addressing significant unmet medical needs in oncology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Lyell Immunopharma, Inc. (0001806952) (Filer) | 2026-04-24 | English | |
| S-3 - Lyell Immunopharma, Inc. (0001806952) (Filer) | 2026-04-03 | English | |
| 4 Filing | 2026-02-12 | English | |
| 4 Filing | 2026-02-12 | English | |
| 4 Filing | 2026-02-12 | English | |
| 4 Filing | 2026-02-11 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 36260618 | ARS - Lyell Immunopharma, Inc. (0001806952) (Filer) | 2026-04-24 | English | ||
| 33301523 | S-3 - Lyell Immunopharma, Inc. (0001806952) (Filer) | 2026-04-03 | English | ||
| 31798780 | 4 Filing | 2026-02-12 | English | ||
| 31798772 | 4 Filing | 2026-02-12 | English | ||
| 31798677 | 4 Filing | 2026-02-12 | English | ||
| 31798747 | 4 Filing | 2026-02-11 | English | ||
| 31798715 | 4 Filing | 2026-02-11 | English | ||
| 31798689 | 4 Filing | 2026-02-11 | English | ||
| 31798684 | 4 Filing | 2026-02-11 | English | ||
| 31798625 | 4 Filing | 2026-02-11 | English | ||
| 31798613 | 4 Filing | 2026-02-11 | English | ||
| 13245391 | Director's Dealing 2026 | 2026-01-06 | English | ||
|
2025
3 filings
| |||||
| 13245392 | 424B5 | 2025-12-18 | English | ||
| 13245393 | Regulatory Filings 2025 | 2025-12-16 | English | ||
| 13245394 | 8-K | 2025-12-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Lyell Immunopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33362/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33362 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33362 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33362 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33362}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lyell Immunopharma, Inc. (id: 33362)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.